Premium
T richoderma species fungemia after high‐dose chemotherapy and autologous stem cell transplantation: a case report
Author(s) -
Festuccia M.,
Giaccone L.,
Gay F.,
Brunello L.,
Maffini E.,
Ferrando F.,
Talamo E.,
Boccadoro M.,
Serra R.,
Barbui A.,
Bruno B.
Publication year - 2014
Publication title -
transplant infectious disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.69
H-Index - 67
eISSN - 1399-3062
pISSN - 1398-2273
DOI - 10.1111/tid.12245
Subject(s) - fungemia , medicine , voriconazole , hematopoietic stem cell transplantation , multiple myeloma , melphalan , autologous stem cell transplantation , transplantation , stem cell , chemotherapy , surgery , oncology , mycosis , dermatology , antifungal , biology , genetics
We present a case of T richoderma fungemia with pulmonary involvement in a multiple myeloma patient, who was severely immunocompromised and heavily treated with high‐dose melphalan, and underwent autologous hematopoietic cell transplantation. This is the first report, to our knowledge, of proven T richoderma fungemia, defined by published criteria, successfully treated with voriconazole.